Myriad Genetics, Inc. (MYGN) Showcases Breakthrough MRD Data and AI-Driven Cancer Tools at ASCO 2025
Myriad Genetics, Inc.
Posts Tagged ‘NASDAQ:MYGN’
Billionaire Larry Robbins’ 10 Stock Picks with Huge Upside Potential
Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call Transcript May 6, 2025Myriad Genetics, Inc. beats earnings expectations.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Myriad Genetics Fourth Quarter 2024 Financial Earnings Conference Call.
Top 8 Trending AI News Updates Investors Should Not Miss
As AI takes over industries worldwide, the technology has begun replacing the redundant human workforce, as popular banks reveal plans to shrink headcount amid rapid AI adoption...
Billionaire Larry Robbins’ Long-Term Stock Picks
Larry Robbins is an American hedge fund manager, philanthropist, and the founder, CEO, and portfolio manager of Glenview Capital, a leading New York-based investment firm.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2024 Earnings Call Transcript
Matt Scalo: Thank you, Franz, and good afternoon, and welcome to the Myriad Genetics third quarter 2024 earnings call.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Myriad Genetics Second Quarter 2024 Financial Earnings Conference Call.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Myriad Genetics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript
Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $0.02. Myriad Genetics, Inc.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2023 Earnings Call Transcript
Matt Scalo: Good afternoon and welcome to Myriad Genetics Third Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Myriad Genetics Second Quarter 2023 Financial Earnings Call [Operator Instructions].
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Call Transcript
Matthew Scalo: Okay. Good afternoon, and welcome to the Myriad Genetics' First Quarter 2023 Earnings Call.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Myriad Genetics Fourth Quarter 2022 Financial Earnings Conference Call.
12 Biggest Genomics Companies In The World
In this article, we will discuss the 12 Biggest Genomics Companies In The World.
10 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins
This article discusses the top 10 healthcare stock picks of billionaire Larry Robbins’ hedge fund Glenview Capital Management.
Were Hedge Funds Right About Myriad Genetics, Inc. (MYGN)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Balaji Srinivasan’s Prediction on China’s Role in Crypto Crash and His Top 10 Investments
In this article, we will take a look at the top 10 investments of Balaji Srinivasan and see his thoughts on China's ability to undermine crypto.
Here is What Hedge Funds Think About Myriad Genetics, Inc. (MYGN)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Never Been Less Bullish On Myriad Genetics, Inc. (MYGN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Buying Myriad Genetics, Inc. (MYGN)
We hate to say this but, we told you so.
Hedge Funds Are Dumping Myriad Genetics, Inc. (MYGN)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible...
Hedge Funds Aren’t Crazy About Myriad Genetics, Inc. (MYGN) Anymore
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
Here’s What Hedge Funds Think About Myriad Genetics, Inc. (MYGN)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Here’s What Hedge Funds Think About Myriad Genetics, Inc. (MYGN)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Myriad Genetics, Inc. (MYGN): Are Hedge Funds Right About This Stock?
Is Myriad Genetics, Inc.
Has the Smart Money Unearthed a Hidden Gem in Myriad Genetics, Inc. (MYGN)?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
How This Fund’s Investments in NorthStar Asset Management (NSAM), CONMED Corporation (CNMD) & Other Stocks Performed in Q3?
SLS Management is a New York-based hedge fund that was founded by Scott Lawrence Swid.
Here’s Why Bristol-Myers Squibb Co (BMY), Telefonica Brasil SA (ADR) (VIV) and Three Other Stocks Plunged on Monday
Markets are trading on an optimistic note as all the major indices are in green zone.
What is Going On With These Falling Stocks?
While crude prices are now at a monthly high and the S&P 500 is above 2,100, some stocks have been left behind. Among the stocks deep in the red today are Rambus Inc.
Is Myriad Genetics, Inc. (MYGN) A Good Stock To Buy?
The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the...
Consonance Capital Management is Fond of Healthcare Stocks
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Qiagen NV (QGEN): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
To many market players, hedge funds are viewed as delayed, old investment vehicles of a period lost to current times.
Hedge Funds Are Crazy About Myriad Genetics, Inc. (MYGN)
In the 21st century investor’s toolkit, there are plenty of gauges shareholders can use to track the equity markets.
Myriad Genetics, Inc. (MYGN), Workday Inc (WDAY), Rackspace Hosting, Inc. (RAX): Three Notable Upgrades on Wednesday
On a day-to-day basis, there are countless analyst calls – some of which are good and others that are bad – and in this piece, I am looking at three in particular to determine...
Qiagen NV (QGEN): Insiders Aren’t Crazy About It
According to most shareholders, hedge funds are assumed to be slow, outdated investment vehicles of the past.
Myriad Genetics, Inc. (MYGN): Big Pharma’s Intellectual Property Blues
It’s not easy being a biotech company.
Why Myriad Genetics, Inc. (MYGN) Shares Swooned Again
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Should You Avoid Forrester Research, Inc. (FORR)?
Forrester Research, Inc. (NASDAQ:FORR) was in 11 hedge funds' portfolio at the end of March. FORR has seen a decrease in hedge fund interest lately.
Judgment Day for Myriad Genetics, Inc. (MYGN)
On June 30, the Supreme Court is going to make a decision on a case filed by the Association for Molecular Biology on human genome patentability against Myriad Genetics, Inc...
Hedge Funds Are Selling Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (NASDAQ:MYGN) was in 19 hedge funds' portfolio at the end of March. MYGN has experienced a decrease in enthusiasm from smart money in recent months.
Myriad Genetics, Inc. (MYGN), Roche Holding Ltd. (ROG): Angelina Jolie’s Selfless Act Heightens Breast Cancer Awareness
I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie...
Sony Corporation (ADR) (SNE) Options Active As Shares Hit Fresh 52-Week High
Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics maker onto our ‘hot...
Sony Corporation (ADR) (SNE) Options Active As Shares Hit Fresh 52-Week High
Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics maker onto our ‘hot...
Biopharma News: Theravance Inc (THRX), VIVUS, Inc. (VVUS), Amgen, Inc. (AMGN)
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Is Myriad Genetics, Inc. (NASDAQ:MYGN) Going to Burn These Hedge Funds?
To the average investor, there are a multitude of methods investors can use to analyze stocks.
2 to Buy & 1 to Sell After Earnings on Monday: Stratasys, Ltd. (SSYS), Santarus, Inc. (SNTS), Myriad Genetics, Inc. (MYGN)
Monday was a somewhat slow day in terms of companies reporting earnings; however like all days during earnings season, opportunity still presented itself.
Can Myriad Genetics, Inc. (MYGN) Survive the Supreme Court?
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics, Inc. (NASDAQ:MYGN) .
